European Journal of Cancer
Volume 39, Issue 9 , Pages 1290-1295 , June 2003

Analysis of survival of mesothelioma cases in the Italian register (ReNaM)

  • A Marinaccio

      Affiliations

    • Department of Occupational Medicine, Epidemiology unit, ISPESL- National Institute for Occupational Safety and Prevention, Via Alessandria 220/E, 00198 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-06-44280396; fax +39-06-44250639
    • ,
  • M Nesti

      Affiliations

    • Department of Occupational Medicine, Epidemiology unit, ISPESL- National Institute for Occupational Safety and Prevention, Via Alessandria 220/E, 00198 Rome, Italy
    • ,
  • Regional Operational Centers

      Affiliations

    • Regional Operational Centers: Corrado Magnani, Cristiana Ivaldi, Paola Dalmasso, Dario Mirabelli, Benedetto Terracini, Annalisa Todesco (Piedmont); Valerio Gennaro, Fabio Montanaro, Anna Lazzarotto, Monica Bianchelli, Maria Vittoria Celesia (Liguria); Silvia Candela, Antonio Romanelli, Lucia Mangone (Emilia-Romagna); Enzo Merler, Elisabetta Chellini, Giuseppe Gorini, Stefano Silvestri, Valentina Cacciarini (Tuscany); Marina Musti, Domenica Cavone (, Puglia), Italy

Received 19 September 2002 ,Revised 19 December 2002 ,Accepted 21 February 2003.

References 

  1. Lanphear B, Buncher C. Latent period for malignant mesothelioma of occupational origin. Occup. Med. 1992;34:718–721
  2. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br. J. Cancer. 1999;79:666–672
  3. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents, vol. VII IARC Scientific Publication. No. 143. Lyon, 1997.
  4. In:  Zanetti R,  Crosignani P,  Rosso S editor. Cancer in Italy. Incidence Data from Cancer Registries—Second Volume 1988–1992. Rome: Il Pensiero Scientifico Editore; 1997;
  5. Seniori Costantini A, Chellini E. The experience of the Mesothelioma Registry in Tuscany in assessing health hazard associated with asbestos exposure. Med. Lav. 1997;88:310–315
  6. Musti M, Palamà L, Cavone D, Bufano V. Atti Vo Convegno Multidisciplinare di Oncologia I tumori di origine industriale (i mesoteliomi, Bari 1998). Eur. J. Oncol. 1999;387–390
  7. Ivaldi C, Dalmasso P, Nesti M, Magnani C. Malignant Mesothelioma Registry from Piedmont. Incidence in 1990–1995. Epidemiol. Prev. 1999;23:308–315
  8. Gennaro V, Montanaro F, Lazzarotto A, Bianchelli M, Celesia MV, Canessa PA. Mesothelioma registry of the Liguria region. Incidence and occupational etiology in a high risk area. Epidemiol. Prev. 2000;24:213–218
  9. Mangone L, Romanelli A, Campari C, Candela S. Malignant mesothelioma in Emilia-Romagna (incidence and asbestos exposure). Epidemiol. Prev. 2002;26:124–129
  10. In:  Nesti M,  Marinaccio A,  Silvestri S editor. Italian mesothelioma register (first report). Rome: ISPESL; 2001;
  11. Fusco V, Ardizzoni A, Merlo F, et al.  Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients. Anticancer Res. 1993;13:683–689
  12. Leigh J, Rogers J, Ferguson AD, Mulder HB, Ackad M, Thompson R. Lung asbestos fiber content and mesothelioma cell type, site and survival. Cancer. 1991;68:135–141
  13. Ruffie P, Feld R, Minkin S, et al.  Diffuse malignant mesothelioma of the pleura in Ontario and Quebec (a retrospective study of 332 patients). J. Clin. Oncol. 1989;7:1157–1168
  14.  Rosso S,  Casella C,  Crocetti E,  Ferretti S,  Guzzinati SSurvival of cancer patients in Italy in the nineties (figures from the cancer registries). Epidemiol. Prev. 2001;25(Suppl.):1–375
  15. Verdecchia, A. and the ITACARE Working Group . Survival of cancer patients in Italy, the ITACARE study. Tumori. 1997;83:1–507
  16. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J. Survival of Cancer Patients in Europe, the EUROCARE Study. IARC Scientific Publication No. 95. International Agency for Research on Cancer; 1995;
  17. Berrino F, Capocaccia R, Estève J, et al.  Survival of cancer Patients in Europe, the EUROCARE2 Study. IARC Scientific Publication No. 151. Lyon: International Agency for Research on Cancer; 1999;
  18. Spirtas R, Connelly R, Tucker M. Survival patterns for malignant mesothelioma (the SEER experience). Int. J. Cancer. 1988;41:525–530
  19. Desoubeaux N, Bouvier V, Gervais R, et al.  Mésothéliomes malins en Basse-Normandie (analyse descriptive, facteurs pronostiques et survie. Une étude de population). Rev. Epidemiol. Sante Publique. 2001;49:523–529
  20. Van Gelder T, Damhuis RAM, Hoogsteden HC. Prognostic factors and survival in malignant pleural mesothelioma. Eur. Respir J. 1994;7:1035–1038
  21. Beer TW, Buchanan R, Matthews AW, Stradling R, Pullinger N, Pethybridge RJ. Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype. Hum. Pathol. 1998;29:246–251
  22. Neumann V, Gunther S, Muller KM, Fischer M. Malignant mesothelioma—German mesothelioma register 1987–1999. Int. Arch. Occup. Environ. Health. 2001;74:383–395
  23. Merritt N, Blewett CJ, Miller JD, Bennett WF, Young JE, Urschel JD. Survival after conservative (palliative) management of pleural malignant mesothelioma. J. Surg. Oncol. 2001;78:171–174

PII: S0959-8049(03)00233-8

doi: 10.1016/S0959-8049(03)00233-8

European Journal of Cancer
Volume 39, Issue 9 , Pages 1290-1295 , June 2003

Article Tools

* Image Usage & Resolution